House Government Operations subcommittee
This article was originally published in The Gray Sheet
Human resources subcommittee staffer Diana Zuckerman joins PHS' Substance Abuse and Mental Health Services Administration Jan. 11 as director of the policy, planning and legislation office in the Center for Mental Health Services. While on the subcommittee, Zuckerman investigated medical device issues such as silicone breast implants and temporomandibular joint implants. Device issues previously overseen by Zuckerman are expected to be picked up by other subcommittee staffers....
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.